Company intelligence / Profile preview

Portland Holdings

Burlington, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Portland Holdings is an investment firm that manages public equity, private equity, and direct ownership in diversified businesses. Its Life and Unifying Sciences (PLUS) division focuses on healthcare innovations, particularly in precision oncology and nuclear medicine. It operates the Portland Life Sciences Alternative Fund, investing in precision oncology companies.

Industry: Investors

Partnerships

ITM Isotope Technologies Munich SEOncoBeta GmbHTelix Pharmaceuticals LimitedCanadian Nuclear Laboratories (CNL)MBM Holding

Beyond the preview

Go deeper on Portland Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Portland Holdings.

Explore the full profile